Abiopharma

EC World REIT is a Singapore real estate investment trust established with the investment strategy of investing principally, directly or indirectly, in a diversified portfolio of income-producing real estate which is used primarily for e-commerce, supply-chain management and logistics purposes, as well as real estate-related assets, with an initial geographical focus on the People’s Republic of China (“PRC” or “China”).
It is also the first Chinese specialised logistics and e-commerce logistics REIT to be listed on the SGX-ST and provides direct exposure to the growing logistics and e-commerce sectors in China.
The initial portfolio of EC World REIT comprises six properties strategically located in Hangzhou. Hangzhou is also one of the most important steel transportation hubs along the Beijing- Hangzhou Grand Canal.Together the six properties cover an aggregate net lettable area of approximately 698,478 square metres and a total appraised value of approximately RMB6,357 million (equivalent to approximately S$1,303 million) as at 31 December 2015.

Additional info from SGX:

EC World REIT is a Singapore real estate investment trust established with the investment strategy of investing principally, directly or indirectly, in a diversified portfolio of income-producing real estate which is used primarily for e-commerce, supply-chain management and logistics purposes, as well as real estate-related assets, with an initial geographical focus on the People’s Republic of China (“PRC” or “China”).
It is also the first Chinese specialised logistics and e-commerce logistics REIT to be listed on the SGX-ST and provides direct exposure to the growing logistics and e-commerce sectors in China.
The initial portfolio of EC World REIT comprises six properties strategically located in Hangzhou. Hangzhou is also one of the most important steel transportation hubs along the Beijing- Hangzhou Grand Canal.Together the six properties cover an aggregate net lettable area of approximately 698,478 square metres and a total appraised value of approximately RMB6,357 million (equivalent to approximately S$1,303 million) as at 31 December 2015.